MedTrace Logo

The Effects of Positive Expiratory Pressure Breathing on The Rate of Post-exercise Recovery in Patients With COPD

NCT02398071 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-03-25

No results posted yet for this study

Summary

Most daily activities involve alternating periods of exercise and rest. If recovery is slow following exercise it means that the next period of activity may be more difficult and the COPD patients becomes restricted in their daily life. Therefore, the investigators are interested to study the effectiveness and physiological effects of breathing with a PEP device during post-exercise period and hypothesize that

1. Post-exercise breathing with PEP device will increase the rate of recovery more than breathing without PEP device.
2. Post-exercise breathing with PEP device will not create harmful effects on cardiopulmonary function in COPD patients.

Conditions

Interventions

DEVICE

A water pressure threshold device (BreatheMAX)

BreatheMAX®, the water pressure threshold breathing device contributed in our laboratory will be used. This device is small, simple, easy to use and also inexpensive since the device is developed and manufactured in Thailand. The depth of water in the body of the device provides the flow resistance during exhalation through the inlet tube in a water cylinder.

Sponsors & Collaborators

  • Khajonsak Pongpanit

    lead OTHER

Principal Investigators

  • Chulee Jones, PhD · School of Physical Therapy, Faculty of Associated Medical Sciences, Khon Kaen University, Thailand

  • Watchara Boonsawat, PhD · Department of medicine, Faculty of medicine, Khon Kaen university, Thailand

  • David A. Jones, PhD · School of Healthcare Science, Faculty of Science and Engineering, Manchester Metropolitan University, United Kingdom

  • Khajonsak Pongpanit, MSc student · School of Physical Therapy, Faculty of Associated Medical Sciences, Khon Kaen University, Thailand

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02398071 on ClinicalTrials.gov